プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Daniel P.に依頼

United States

Technical and medical writer with expertise in writing of peer-reviewed articles, white papers and regulatory reports.

プロフィール概要

I can bring to your project a depth of knowledge and expertise from more than five years of experience writing articles for publication, review articles, and regulatory reports. I also have received training (Essential Skills Certificate Program) through the American Medical Writers Association. Prior to my time as a medical writer, I have had 15 years of experience in basic research and drug discovery research. Areas of expertise include oncology, cardiovascular, gastroenerology, diabetes, hematology, and immunology.

専門分野

• ★ Oncology
• ☆ Gastroenterology & Hepatology
• ☆ Hematology
• ☆ Cardiovascular Disease
• ☆ Medical Writing

サービス

• Writing

Writing Clinical Trial Documentation, Technical Writing

職務経験

Medical Writer

The Conjugate Group

6月 2019 - 10月 2019

medical writer

Innovative Science Solutions LLC

6月 2016 - 1月 2019

Senior Medical Writer

Randstad at EMD Serono (contract)

6月 2014 - 6月 2015

consultant

Beantown Biotech LLC

9月 2012 - 2月 2013

Senior Research Associate

Avila Therapeutics

1月 2011 - 5月 2012

scientist

Randstad at AstraZeneca (contract)

5月 2008 - 5月 2010

Applications Specialist

PerkinElmer Life and Analytical Sciences Inc

9月 2005 - 9月 2006

scientist

Curis Inc

1月 2002 - 8月 2005

Instructor

Beth Israel Deaconess Medical Center

12月 1994 - 12月 2001

学歴

PhD., M.S. (Biochemistry)

University of Tennessee

- 現在

B.A. (Biology)

Johns Hopkins University

- 現在

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2002). The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways . Cell communication & adhesion.

(2001). Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells . Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

(1999). CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells . Biochemical and biophysical research communications.

(1999). Regulation of megakaryocytopoiesis and platelet production by tyrosine kinases and tyrosine phosphatases . Methods (San Diego, Calif.).

(1997). Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes . The Journal of biological chemistry.

(1995). The MATK tyrosine kinase interacts in a specific and SH2-dependent manner with c-Kit . The Journal of biological chemistry.